These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. In-vitro demonstration of cell-mediated immunity to vaccinia virus in man. Koszinowski U; Volkmann B; Thomssen R Z Immunitatsforsch Exp Klin Immunol; 1975 May; 148(5):451-61. PubMed ID: 171872 [TBL] [Abstract][Full Text] [Related]
7. Cellular immune response to measles, mumps, and vaccinia viruses in multiple sclerosis. McFarland HF; McFarlin DE Ann Neurol; 1979 Aug; 6(2):101-6. PubMed ID: 315204 [TBL] [Abstract][Full Text] [Related]
8. Viral antibodies in twins with multiple sclerosis. Woyciechowska JL; Dambrozia J; Leinikki P; Shekarchi C; Wallen W; Sever J; McFarland H; McFarlin D Neurology; 1985 Aug; 35(8):1176-80. PubMed ID: 4040615 [TBL] [Abstract][Full Text] [Related]
9. The lymphoproliferative response to measles virus in twins with multiple sclerosis. Greenstein JI; McFarland HF; Mingioli ES; McFarlin DE Ann Neurol; 1984 Jan; 15(1):79-87. PubMed ID: 6608918 [TBL] [Abstract][Full Text] [Related]
10. [Measles cellular immunity in patients with multiple sclerosis]. Atanadze SN; Kodkind GKh; Smirnov YuK ; Khomak VIa; Veĭn AM Vopr Virusol; 1980; (2):166-9. PubMed ID: 6992452 [TBL] [Abstract][Full Text] [Related]
11. Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination. Epstein LB; Stevens DA; Merigan TC Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2632-6. PubMed ID: 4506785 [TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis: cellular and humoral immune responses to several viruses. Fuccillo DA; Madden DL; Castellano GA; Uhlig L; Traub RG; Mattson J; Krezlewicz A; Sever JL Neurology; 1978 Jun; 28(6):613-5. PubMed ID: 206860 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. Kantor J; Irvine K; Abrams S; Kaufman H; DiPietro J; Schlom J J Natl Cancer Inst; 1992 Jul; 84(14):1084-91. PubMed ID: 1619682 [TBL] [Abstract][Full Text] [Related]
14. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination. Kennedy JS; Frey SE; Yan L; Rothman AL; Cruz J; Newman FK; Orphin L; Belshe RB; Ennis FA J Infect Dis; 2004 Oct; 190(7):1286-94. PubMed ID: 15346340 [TBL] [Abstract][Full Text] [Related]
15. Age distribution for T cell reactivity to vaccinia virus in a healthy population. Hsieh SM; Pan SC; Chen SY; Huang PF; Chang SC Clin Infect Dis; 2004 Jan; 38(1):86-9. PubMed ID: 14679452 [TBL] [Abstract][Full Text] [Related]
16. Decreased cell-mediated immunity to respiratory syncytial virus in multiple sclerosis. Schauf V; Schauf CL; Mizen M; Davis FA Acta Neurol Scand; 1981 Dec; 64(6):383-93. PubMed ID: 7347997 [TBL] [Abstract][Full Text] [Related]
17. Further studies of viral antibodies in the cerebrospinal fluid of patients with multiple sclerosis: vaccinia and parainfluenza type 1. Brown P; Cathala F; Gajdusek DC Proc Soc Exp Biol Med; 1973 Jul; 143(3):828-9. PubMed ID: 4352535 [No Abstract] [Full Text] [Related]
18. The effect of levamisole on cellular immunity in multiple sclerosis. Dau PC; Johnson KP; Spitler LE Clin Exp Immunol; 1976 Nov; 26(2):302-9. PubMed ID: 991460 [TBL] [Abstract][Full Text] [Related]
19. Measles and vaccinia antibodies in multiple sclerosis. Adams JM JAMA; 1978 Aug; 240(7):637. PubMed ID: 671683 [No Abstract] [Full Text] [Related]
20. Immunological reactions against Mycoplasma pneumoniae in multiple sclerosis: preliminary findings. Maida E J Neurol; 1983; 229(2):103-11. PubMed ID: 6190995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]